In autoimmune conditions, including systemic lupus erythematosus (SLE), central nervous system autoimmunity, and autoimmune vasculitis, CD47 overexpression exacerbates inflammation, while blockade enhances efferocytosis and promotes immune resolution, thereby attenuating disease severity [123,124]. Here, CD47 is linked to systemic lupus erythematosus.